Publications found:
33,058
Sort by:
Pharmacy Retail Market in Philippines 2013
US$ 1,950.00
... . Netscribes’ latest market research report titled Pharmacy Retail Market in Philippines 2013 identifies the healthcare scenario, more specifically, the pharmacy retail scenario in the Philippines. The sector is dotted ...
October 2013
75 pages
Global RNAi Drug Pipeline Analysis
US$ 1,500.00
... location. “Global RNAi Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed based upon RNAi technology. ... Drug market based upon development process. Following parameters for each drug profile in development phase are covered in “Global RNAi Drug Pipeline ...
October 2013
250 pages
Global DNA Vaccine Pipeline Analysis
US$ 1,500.00
... West Nile Virus to be used in horses was approved in 2005. 'Global DNA Vaccine Pipeline Analysis' by PNS Pharma gives comprehensive insight on the various ... holders to identify and analyze the available investment opportunity in the DNA vaccine market based upon development process. Following parameters for ...
October 2013
130 pages
US Orphan Drug Pipeline Analysis
US$ 1,800.00
... from rare disease. In US, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the ... increasing, thus increasing the profit margins in the future. “US Orphan Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ...
October 2013
880 pages
Global Infertility Drug Pipeline Analysis
US$ 1,000.00
... drugs and treatment. The most lucrative markets for infertility drugs are the emerging nations such as India, Brazil, China and Mexico, ... pool of people being affected by lifestyle diseases, thus leading to infertility. “Global Infertility Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the ...
October 2013
60 pages
Orphan Drugs for Cancer Pipeline Analysis
US$ 1,800.00
... patient population which suffers from rare or orphan diseases. Among the category of new orphan drugs, Oncology account for the largest disease group ... drug profile in development phase are covered in “Orphan Drugs for Cancer Pipeline Analysis” research report: Drug Profile Overview Alternate Names for Drug ...
October 2013
855 pages
Global HIV Infection Drug Pipeline Analysis
US$ 1,500.00
... to identify and analyze the available investment opportunity in the HIV Infection drug market based upon development process. Following parameters for each drug profile in clinical development phase are covered in “Global HIV Infection Drug Pipeline Analysis” research report: Drug ...
October 2013
300 pages
US Alzheimer Drug Pipeline Analysis
US$ 2,000.00
... observed that almost 1 in 8 people coming under the 65+ age group are patients of Alzeimer’s disease. Amongst the population in the 80+ age group, almost ... market based upon development process. Following parameters for each drug profile in development phase are covered in “US Alzheimer Drug Pipeline Analysis” ...
October 2013
348 pages
US Prostate Cancer Drug Pipeline Analysis
US$ 1,800.00
... Clinical Trial Owner / Originator/ Licensee/Collaborator Administrative Route Drug Class ATC Codes US Prostate Cancer Drug Pipeline by Clinical Phase: Research: 11 Preclinical: 44 Unknown Phase: 4 Phase 0: 1 Phase-I: 22 Phase-I/II: 18 Phase-II: 53 Phase-II/III: 1 Phase-III:14 Marketed: 13
October 2013
375 pages
US Breast Cancer Drug Pipeline Analysis
US$ 1,800.00
... and new therapies would account for more than 25% of the overall market for breast cancer drug treatments. “US Breast Cancer Drug Pipeline Analysis” by ... drug market based upon development process. Following parameters for each drug profile in development phase are covered in “US Breast Cancer Drug Pipeline ...
October 2013
480 pages
Europe Breast Cancer Drug Pipeline Analysis
US$ 1,800.00
... opportunity in the Breast Cancer drug market based upon development process. Following parameters for each drug profile in development phase are covered in “Europe Breast Cancer Drug Pipeline Analysis” research report: Drug Profile Overview Alternate Names ...
October 2013
380 pages
Pharmaceutical Companies Directory-USA-Excel Format
US$ 197.00
This is a directory of 1,333 professionals in U.S. Pharmaceutical companies in Microsoft Excel format. It is searchable, and exportable for use in mailings and lead generation. This database includes the following fields, where available: Company name Mailing address City State Zip (easy sorting by ...
September 2013
1333 pages
Global Facial Injectables Market Report: 2013 Edition
US$ 800.00
... Galderma, Bloomage BioTechnology and Beijing Emeical BioTechnology. This report provides an analysis of the global facial injectables market. It discusses major challenges faced by the industry along ...
September 2013
65 pages
The U.S. Medical Marijuana Market
US$ 995.00
... 2018. There are the about 1,700-2,000 medical marijuana retail dispensaries now operating in the United States, operating in a very uncertain but improving ... public opinion and tax revenue-hungry states are fueling optimism about the medical marijuana (cannabis) market, but significant hurdles remain. ...
September 2013
129 pages
Research Report on China Measles, Mumps and Rubella (MMR) Vaccine Market, 2013-2017
US$ 1,200.00
... (incidence rate: below 1/100,000,000). In 2012, China's lot released volume of measles vaccines reached 8.651 million person-servings, decreasing ... vaccines manufactured by Merck violated the approval process of imported vaccines in China because it lacked alerts in the specification and existed safety risks. ...
September 2013
20 pages
Research Report on China Human Rabies Vaccine Industry, 2013-2017
US$ 1,200.00
... , but the rabies vaccination rate of dogs is less than 10%. Second, China lacks a coordination and management mechanism among departments involving in rabies ... the following information or even more: Development environment of China human rabies vaccines China rabies status overview Supply and demand status ...
September 2013
20 pages
China Pharmaceuticals Industry Profile - ISIC2423
US$ 580.00
... , municipalities, and autonomous regions, the ZEEFER Industry Distribution Index is specially designed to truly reflect the conditions of regional distribution for China pharmaceuticals industry, providing a quantitative, visual and reliable reference for relevant users to make decisions. The ZEEFER Industry ...
September 2013
28 pages
Emergency Contraception in the Netherlands
US$ 990.00
... low in the Netherlands, perhaps explained by the relatively low level of unwanted pregnancies amongst the young population. Euromonitor International's Emergency Contraception in Netherlands report offers ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...
September 2013
23 pages
Gene Therapy Drug Pipeline Analysis
US$ 1,500.00
... in development phase enables the reader to identify and understand the Gene Therapy associated with the various diseases. This report enables pharmaceutical ... parameters for each drug profile in development phase are covered in “Gene Therapy Drug Pipeline Analysis” research report: Drug Profile Overview ...
September 2013
185 pages
UK Injectables Market Outlook to 2017
US$ 1,200.00
... industry in recent years. According to RNCOS’ research report, “UK Injectables Market Outlook to 2017”, the market is anticipated to grow at a CAGR of approximately 4.5% during 2012- ... , Rheumatic Diseases & Gout, etc. Not only this, the report also provides the sales trend of the top 10 injectable drugs in the ...
August 2013
45 pages
Drug Injection Devices to 2018
US$ 4,850.00
... is pleased to announce the publication of a new market study. Drug Injection Devices to 2018: Devices, Markets, Strategies and Forecasts is a comprehensive evaluation and ... benefit from this study. The Proliferation and Penetration of New Injection Device Technology The past decade has seen a dramatic shift ...
August 2013
265 pages
Emergency Contraception in South Africa
US$ 990.00
... afford to buy emergency contraceptive pills if they happen to have unprotected sexual intercourse. Emergency contraceptive pills are relatively expensive for an average person in South Africa, as the unit price averages around R44 for a single tablet. Growth in value sales for contraceptive pills in South Africa is... Euromonitor International's Emergency Contraception in South Africa report ...
August 2013
20 pages
Research Report on China's Haemophilus Influenza B (HIB) Vaccine Industry, 2013-2017
US$ 1,200.00
... influenza type B is a kind of haemophilus influenza with extremely strong invasiveness. Among all the serious infections caused by haemophilus influenzas, almost 90% were caused by haemophilus influenza type B. According to the researches in recent years, HIB has become the first bacteria that will cause ...
August 2013
20 pages
Emergency Contraception in Portugal
US$ 990.00
... also impacted on sales of emergency contraception. Due to their precarious financial situation, many couples have no choice... Euromonitor International's Emergency Contraception in Portugal report offers a comprehensive guide ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...
August 2013
21 pages
Calming and Sleeping in Iran
US$ 990.00
Calming and sleeping is a relatively new OTC category in Iran. There is wide range of domestic and imported brands in the category, ... for sleeping aids. While OTC sales of synthetic calming and sleeping products are not permitted under the regulations of the... Euromonitor International's Calming and Sleeping in Iran ...
August 2013
16 pages
Emergency Contraception in Belgium
US$ 990.00
... young, are still studying or do not want children. Euromonitor International's Emergency Contraception in Belgium report offers a comprehensive guide to the size and shape of the ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...
August 2013
30 pages
Emergency Contraception in Austria
US$ 990.00
... . Emergency contraception was strongly influenced by this in 2012. In addition, the performance of the category was influenced by the fact that the first ever emergency contraception brand was introduced only in January 2010 in Austria, which still leaves a great deal of room... Euromonitor International's Emergency Contraception in Austria report offers ...
August 2013
21 pages
Emergency Contraception in Switzerland
US$ 990.00
The availability of OTC emergency contraception in Switzerland, as well as the more liberal attitudes of Swiss youngsters, drove sales of emergency contraception over the review period. Emergency contraception is mainly used by young women, many of whom do not have access to information about preventative birth control methods. Euromonitor International's Emergency Contraception in Switzerland report ...
August 2013
25 pages
Global Pharmaceutical Industry 2013-2018: Trend, Profit, and Forecast Analysis, August 2013
US$ 4,850.00
... global management consulting and market research firm, has conducted a competitive analysis of the industry and presents its findings in “Global Pharmaceutical Industry 2013-2018: Trend, Profit ... Global pharmaceutical industry annual trend (2007-2012) and forecast (2013-2018) Porter’s Five Force analysis New product launch, merger and acquisition activity in global pharmaceutical industry ...
August 2013
165 pages
Calming and Sleeping in Kenya
US$ 990.00
... hectic lifestyles, stress and stress-induced insomnia. Euromonitor International's Calming and Sleeping in Kenya report offers a comprehensive guide to the size and shape ... . Why buy this report? Get a detailed picture of the Calming and Sleeping market; Pinpoint growth sectors and identify factors driving change ...
August 2013
15 pages
Calming and Sleeping in Cameroon
US$ 990.00
... value sales of calming and sleeping products in Cameroon were up by 5% in 2012. Demand grew mostly due to population growth and a rise in urbanisation. In Cameroon these products are ... by stress among upper- and middle-income consumers. Euromonitor International's Calming and Sleeping in Cameroon report offers a comprehensive guide to the size and shape ...
August 2013
16 pages
Emergency Contraception in Cameroon
US$ 990.00
... hold the view that the product is abortive. Euromonitor International's Emergency Contraception in Cameroon report offers a comprehensive guide to the size and shape of the ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...
August 2013
15 pages
Research Report on Global and China Human Vaccine Industry, 2013-2017
US$ 2,200.00
... Type B Haemophilus Influenzae Conjugate Vaccine, Influenza Vaccine, Rabies Vaccine and so on. In China, Vaccine I market are occupied by state-owned enterprises, while foreign- ... market will rise continually. Due to the low vaccination rate in China, there's much space for future growth. With the increase of ...
August 2013
50 pages
Malaria Disease Drug Pipeline Analysis
US$ 1,200.00
... purchasing Hard Copy License depending on the location. “Malaria Disease Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ... on the development process. Insight for each drug profile in development phase enables the reader to identify and understand the therapeutics associated ...
August 2013
185 pages
Pharma and Gamification: motivating positive outcomes – a primer
US$ 595.00
... how gamification can influence product innovation Understand how gamification can change clinician and patient behavior Be ready for future developments. Pharma and Gamification: motivating positive outcomes – a primer answers key questions: How is the global gamification market evolving? How are pioneering Pharma companies involved in gamification? Why has Pharma ...
July 2013
56 pages
Emergency Contraception in New Zealand
US$ 990.00
Emergency contraception continued to be an acceptable medical method of preventing pregnancy within New Zealand during 2012. While abortion services are provided for free within New Zealand for ... disagreement, however, in general there is a high level of approval of emergency contraception products in... Euromonitor International's Emergency Contraception in New Zealand report offers a comprehensive guide to the size and shape ...
July 2013
28 pages
OTC Triptans in New Zealand
US$ 990.00
During 2012 there were only two OTC triptan products available in New Zealand, Sumagran Active (Mylan New Zealand) and Zomig (AstraZeneca). Several other prescription products ... -Sumatriptan, however only the latter was subsidised. Euromonitor International's OTC Triptans in New Zealand report offers a comprehensive guide to the size and shape of the ...
July 2013
31 pages
Emergency Contraception in Bulgaria
US$ 990.00
... the product, but also created awareness of emergency contraception products, and their usage... Euromonitor International's Emergency Contraception in Bulgaria report offers a comprehensive guide to the size ... data. Why buy this report? Get a detailed picture of the Emergency Contraception market; Pinpoint growth sectors and identify factors driving change ...
July 2013
17 pages
Emergency Contraception in the United Kingdom
US$ 990.00
... 2012, emergency contraception increased by 3% in current value terms, to reach £25 million. After the introduction of OTC emergency contraceptive pills in 2001, growth was initially rapid, as women chose the option of convenience, and purchased in a pharmacy. Euromonitor International's Emergency Contraception in United Kingdom report ...
July 2013
29 pages
OTC Triptans in the United Kingdom
US$ 990.00
... security, resulting in an increase in migraines and headaches in general. Euromonitor International's OTC Triptans in United Kingdom report offers a comprehensive guide to the size and shape of the ... data. Why buy this report? Get a detailed picture of the OTC Triptans market; Pinpoint growth sectors and identify factors driving change ...
July 2013
30 pages
Orphan Drugs for Cancer: R&D and Market 2013-2023
US$ 2,635.00
... assess trends, possibilities, and innovations What about R&D - pipelines for new drugs? You assess trends and technologies there, especially in these applications ... - explore activities, results, R&D, and outlooks for future success. Orphan Drugs for Cancer: R&D and Market 2013-2023 gives independent analysis ...
July 2013
179 pages
China Pharmaceutical & Medicine Market Report
US$ 680.00
This report presents a clear picture about the overall development of pharmaceutical & medicine market in China and the trend in recent years based on detailed data ... and the value of imports... The report offers data on the market shares of imported products, foreign enterprises and enterprises in other forms. ...
July 2013
50 pages
China Pharmaceutical Raw Materials Market Report
US$ 680.00
... report presents a clear picture about the overall development of pharmaceutical raw materials market in China and the trend in recent years based on detailed data ... and the value of imports... The report offers data on the market shares of imported products, foreign enterprises and enterprises in other forms. ...
July 2013
54 pages
Protein Target & Pipeline Database: 1-Year Subscription
US$ 1,588.00
... sources can be viewed and printed. Sales figures of major therapeutic proteins on the market are provided. An advanced search function allows to combine ... by e-mail within 24 hours after purchase. Benefits from the Protein Target & Pipeline Database: Intuitive use Designed for structured searches Focused ...
July 2013
World Pain Relieving Drug Market 2013-2023
US$ 2,635.00
... novel opioids, cannabinoids and local anaesthetics Non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids and aldose reductase inhibitors Disease modifying anti- ... This decade, many opportunities will arise. Eight ways World Pain Relieving Drug Market 2013-2023 benefits you In particular, then, our ...
July 2013
257 pages
Emergency Contraception in India
US$ 990.00
Emergency contraception in India increased by 24% in current value terms in 2012. There has been a great ... . It was an emerging category back in 2008. Emergency contraception is a relatively new concept to Indian women, and manufacturers which have understood... Euromonitor International's Emergency Contraception in India report offers ...
July 2013
31 pages
Calming and Sleeping in Dominican Republic
US$ 990.00
... the review period, consistent improvements in the economic conditions in the Dominican Republic gave rise to a burgeoning middle class. However, this general growth ... has led to significant increases in the stress... Euromonitor International's Calming and Sleeping in Dominican Republic report offers a comprehensive guide to the size and shape of the ...
July 2013
24 pages
Inflammatory Bowel Diseases: World Drug Market 2013-2023
US$ 2,635.00
... market from 2013, including these: Nature of ulcerative colitis and Crohn's disease Aetiology and epidemiology of IBD Monoclonal antibodies (mAbs) as medications Delivery ... possibilities, helping you stay ahead. Eight ways Inflammatory Bowel Diseases: World Drug Market 2013-2023 helps you To sum up, then ...
July 2013
120 pages
